Cantor Fitzgerald analyst Steven Halper reiterated a Hold rating on Humana Inc (HUM) today and set a price target of $320. The company’s shares opened today at $283.59.
Halper noted:
“. We reiterate our Neutral rating on HUM shares and maintain our price target of $320. the company hosted an analyst meeting where it focused on its IT and provider investments as vehicles to improve health plan performance. During the company’s presentation, it indicated it was not worried about the proposed changes to Medicare Part D rebates. It is currently working on different scenarios that could be included in the final rule. More importantly, the company identified that the return of the Health Insurance Fee (HIF) is a potential headwind in 2020.”
According to TipRanks.com, Halper is a top 100 analyst with an average return of 17.5% and a 62.1% success rate. Halper covers the Services sector, focusing on stocks such as WellCare Health Plans, Tivity Health Inc, and Hms Holdings Corp.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Humana Inc with a $361.20 average price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $355.88 and a one-year low of $261.35. Currently, Humana Inc has an average volume of 1.1M.
Based on the recent corporate insider activity of 60 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Humana Inc. engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty, Healthcare Services, and Individual Commercial.
